METTL6 and ovarian neoplasm: Interestingly, METTL6 mRNA levels showed no significant difference between ovarian tumors and normal ovarian tissues (Figure 1A; Figure S1C, Supporting Information) and did not correlate with patient prognosis (Figure 1I).